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Diffraction (X-ray, neutron and electron) and electron cryo-microscopy are
powerful methods to determine three-dimensional macromolecular structures,
which are required to understand biological processes and to develop new
therapeutics against diseases. The overall structure-solution workflow is similar
for these techniques, but nuances exist because the properties of the reduced
experimental data are different. Software tools for structure determination
should therefore be tailored for each method. Phenix is a comprehensive
software package for macromolecular structure determination that handles data
from any of these techniques. Tasks performed with Phenix include data-quality
assessment, map improvement, model building, the validation/rebuilding/
refinement cycle and deposition. Each tool caters to the type of experimental
data. The design of Phenix emphasizes the automation of procedures, where
possible, to minimize repetitive and time-consuming manual tasks, while default
parameters are chosen to encourage best practice. A graphical user interface
provides access to many command-line features of Phenix and streamlines the
transition between programs, project tracking and re-running of previous tasks.
1. Introduction
Macromolecules are essential for biological processes within
organisms, engendering the need to understand their behavior
to explain the fundamentals of life. The function of macro-
molecules correlates with their three-dimensional structure,
i.e. how the atoms of the molecule are arranged in space and
how they move over time. Two major methods to obtain
macromolecular structures are diffraction (usually using
X-rays, but also neutrons or electrons) and electron cryo-
microscopy (cryo-EM1) (Fig. 1), both of which are handled by
Phenix. The following subsections describe some concepts
ISSN 2059-7983
1 A consensus for the name is not yet established: both the terms ‘cryo-
electron microscopy’ and ‘electron cryo-microscopy’ can be found in the
literature (Jensen, 2010).
underpinning each method for the benefit of readers who are
not experts in each of these areas.
1.1. X-ray diffraction
X-ray diffraction relies on the interaction of X-rays with the
electron cloud of atoms in a crystal. As the atomic core
electron density dominates the electron-density distribution,
major peaks equate to atomic positions and can be used to
determine the structure. An exception is the H atom because it
possesses only one valence electron, the distribution of which
is shifted towards its covalent-bond partner. The electron
density in the unit cell is related to the Fourier transform of
the amplitude and phase of the scattered X-rays. As only the
intensities of the waves can be measured, the phase informa-
tion is lost and has to be inferred by various methods (Section
4.1).
Of the models deposited in the Protein Data Bank (PDB;
Bernstein et al., 1977; Burley et al., 2019), 89% originate from
X-ray crystallography. Since the first protein structures were
determined in the 1950s (Kendrew et al., 1958; Perutz et al.,
1960), the method has experienced many methodological and
technological developments and is now considered to be quite
mature (Wlodawer et al., 2013). Nevertheless, structures
determined at low resolution (for example, worse than 3 A˚)
remain challenging and could benefit from some of the new
developments for cryo-EM that target similar resolution
ranges.
1.2. Neutron diffraction
Neutron diffraction, which relies on the same formalism as
X-ray diffraction, is based on the interaction of neutrons with
atomic nuclei and therefore yields actual atomic positions
directly. As the neutron scattering cross-section varies by
element (or isotope) in a nonlinear fashion, the scattering
lengths of light atoms such as hydrogen and deuterium (D)
atoms are similar to those of the heavier atoms (C, O and N).
It is therefore possible to locate H (or D) atoms and to deduce
their protonation states; this knowledge helps in under-
standing catalytic mechanisms and ligand binding (Yamaguchi
et al., 2009; Bryan et al., 2013; Knihtila et al., 2015). Further-
more, the neutron scattering length can be positive or negative
(it is always positive for X-rays). For example, H has a nega-
tive scattering length, the magnitude of which is about half of
the scattering length of carbon. The nuclear scattering length
density can therefore cancel out for groups such as CH2, which
occur frequently in macromolecules. To avoid negative scat-
tering from H atoms, hydrogen can be partially or fully
exchanged with deuterium by soaking the crystal in deuter-
ated buffer solutions or by performing protein expression in
fully deuterated reagents, respectively.
The number of structures determined by neutron crystallo-
graphy (0.1% of the models deposited in the PDB) is small
compared with the number of X-ray structures (89%).
Neutron diffraction is not used to solve the structure of a
macromolecule de novo as it requires considerable effort to
prepare deuterated crystals suitable for the experiment.
Instead, neutron diffraction provides complementary infor-
mation because it enables the location of H or D atoms.
1.3. Cryo-EM
Cryo-EM relies on the interaction of electrons with the
electrostatic field of the atoms in the sample. The method
comprises many techniques, such as electron tomography,
electron single-particle microscopy and electron crystallo-
graphy. Single-particle analysis is a commonly used variant
that combines 2D projection images of macromolecules into a
3D reconstruction (electrostatic potential map or cryo-EM
map). This is in contrast to diffraction experiments, in which
the phase information is lost (in the absence of experimental
phases, electron-density maps thus have to be calculated using
a model). While being visually similar to electron-density
maps from X-ray diffraction, a cryo-EM map exhibits some
differences, such as negative peaks from negatively charged
nucleic acids (Wang & Moore, 2017). Furthermore, the
reconstruction process and motion or heterogeneity of the
sample can lead to blurring of cryo-EM maps; high-resolution
details can be revealed by operations such as map sharpening
(Section 4.2).
Cryo-EM was traditionally employed to investigate large
protein and nucleic acid complexes, filaments and viruses, but
was often limited to resolutions worse than 5 A˚. Technological
advances, such as the development of direct electron detectors
(Li et al., 2013) and improvements in image processing (Bai et
al., 2015), have transformed the method, leading to cryo-EM
maps with greatly improved resolution. More recently, 3D
reconstructions have routinely attained resolutions signifi-
cantly better than 4 A˚, allowing atomic model interpretation
and the solution of structures de novo. Cryo-EM has thus
become another principal method of macromolecular struc-
ture determination (2% of the models deposited in the PDB).
For large molecules and structures determined at low resolu-
tion, annual depositions of cryo-EM models now outnumber
those of X-ray models (Figs. 2 and 3).
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Figure 1
Experimental methods used to determine macromolecular structures that
are deposited in the PDB. The predominant method is X-ray diffraction,
followed by nuclear magnetic resonance (NMR), cryo-EM and neutron
diffraction.
1.4. Other techniques
Another method to determine macromolecular structures
is NMR (nuclear magnetic resonance; 9% of the models
deposited in the PDB), which uses the quantum properties of
atomic nuclei. Phenix does not have tools for structure
determination using NMR data, so it is not addressed here.
Electron diffraction on nearly single-layer crystals is an
emerging technique to determine high-resolution structures of
macromolecules. It accounts for a slightly smaller number of
models in the PDB than neutron diffraction.
1.5. Phenix
Phenix (Adams et al., 2002, 2010) is a software suite that
uses reduced data from X-ray diffraction, electron diffraction,
neutron diffraction or cryo-EM to determine macromolecular
structures. Each method has a different approach to derive
structural information, with Phenix offering specific tools to
address the unique properties of the experimental data.
Emphasis is put on the automation of all procedures to avoid
burdening the user with repetitive, time-consuming and often
error-prone tasks. Another important feature is the user-
friendly design, which makes the program accessible to novice
users while keeping it flexible for experts. New tools are
regularly developed or enhanced to improve the structure-
solution workflow. For example, a series of programs which
focuses on the analysis of cryo-EM maps and models has
recently been created to answer the emerging needs of the
cryo-EM community.
This article describes the structure-determination process of
three methods (X-ray diffraction, neutron diffraction and
cryo-EM), summarizes major tools and reports recent
developments in Phenix.
2. Steps in the structure-solution process
Fig. 4 shows the steps of the structure-solution process for
X-ray/neutron crystallography and cryo-EM. Owing to the
different nature of the interactions, there are nuances for each
structure-determination method (Figs. 5 and 6), but the overall
procedure to obtain a molecular model is similar. The first step
consists of analyzing the derived experimental data to detect
any anomalies that can complicate or even prevent structure
determination (Section 3). The second and third steps are to
obtain the best possible map (Section 4) so that a model can be
built (Section 5). The fourth step focuses on iteratively
improving the model by cycles of local rebuilding, refinement
and validation (Sections 6 and 7). The subsequent sections
elaborate on the steps and explain similarities and differences
for X-ray/neutron crystallographic and cryo-EM data. The
Phenix tools that perform the corresponding steps are
described.
3. Data-quality assessment
Data quality should be analyzed carefully because unusual
features can thwart structure solution. If the data have
anomalies, it is not guaranteed that they can be addressed at
later stages, in which case it might be necessary to perform
new experiments or re-analyze the raw data.
3.1. Crystallography
3.1.1. Xtriage. Macromolecular crystals are prone to
pathologies and rarely achieve perfect order, as the molecules
interact weakly with each other. For example, a crystal is
called ‘twinned’ if two or more crystals (domains) are inter-
grown in such a way that their orientations are related by a
specific geometrical operation (a twin operation; Hahn &
Klapper, 2006). The overlap of diffraction spots adds noise to
the measurements and reduces the information content of the
data. Translational noncrystallographic symmetry (tNCS) is
another pathology that complicates structure determination.
This arises when more than one copy of a molecule or
assembly is found in a similar orientation in the asymmetric
feature articles
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Figure 3
Since 2015, cryo-EM depositions have accounted for the majority of large
macromolecular structures.
Figure 2
Annual cryo-EM model depositions now outnumber X-ray model
depositions in the resolution range 3.5–5 A˚.
unit of the crystal. Interference effects between diffraction
from the copies lead to an overall modulation of the intensities
in the diffraction pattern.
The program Xtriage (phenix.xtriage) identifies twinning,
tNCS and other unusual features of diffraction data (Zwart et
al., 2005). To detect twinning, the tool examines amplitude and
intensity ratios, |E2  1| values, the L-statistic (Padilla &
Yeates, 2003) and N(Z) plots (Howells et al., 1950). The twin
fraction is estimated by interpreting the Britton plot2 (Britton,
1972) and performing the H-test
(Yeates, 1997). Xtriage reveals tNCS
using the native Patterson function and
uses database-derived Wilson plots to
find anomalies in the mean intensity.
The tool also analyses reflection
merging statistics to detect whether the
input data symmetry is too low, and
systematic absences to identify screw
axes. A warning is issued if ice rings are
detected. Apart from identifying
pathologies, Xtriage also reports data-
quality indicators, such as the signal-to-
noise ratio and data completeness.
Furthermore, the tool estimates anom-
alous signal strength based on the frac-
tion of statistically significant Bijvoet
differences (Zwart, 2005) and the
overall anisotropic scale factor using the
likelihood formalism described by
Popov & Bourenkov (2003).
3.1.2. Planning and assessing a SAD
experiment. Before conducting a single-
wavelength anomalous diffraction
(SAD) experiment, it is useful to assess
its chances of success. Plan SAD
experiment (phenix.plan_sad_experiment)
is a new tool for estimating the anom-
alous signal from a SAD experiment
with a particular anomalous scatterer
and data quality, and for predicting
whether this signal would be sufficient
to solve the structure (Terwilliger et al.,
2016a,b). The tool provides a summary
of the anomalous signal required and
what can be expected if the data can be
measured with the suggested overall
signal-to-noise ratio (I/). Once data
have been collected and then scaled
with the Scale and Merge Data
(phenix.scale_and_merge) tool, the
Anomalous Signal (phenix.anomalous_
signal) tool estimates the amount of
signal that has actually been achieved
and predicts whether or not this will be sufficient to solve the
structure.
3.2. Cryo-EM: Mtriage
The sample for a cryo-EM experiment is not crystalline, so
many of the problems discussed in the previous section
(Section 3.1.1) are not relevant. However, the quality of the
reconstruction and therefore the interpretability of a cryo-EM
map can deteriorate from many causes, such as structural
heterogeneity, radiation damage and beam-induced sample
movement. The information content of a cryo-EM map is
typically expressed by the resolution. While the same term
feature articles
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Figure 4
The structure-solution steps for X-ray/neutron crystallography and cryo-EM have nuances for each
technique, but the overall workflow is similar. Color code: cryo-EM, gray; X-ray crystallography,
green; neutron crystallography, red. As neutron diffraction experiments are typically performed
with samples for which the structure is known, the phasing, density modification and model-building
steps are not part of the workflow.
Figure 5
The primary tools for X-ray crystallography in Phenix.
2 The number of negative intensities after detwinning as a function of the twin
fraction.
(‘resolution’) is used in crystallography
to describe data quality, its meaning
differs: the resolution of a crystallo-
graphic data set depends on the largest
angle to which diffracted beams were
measured or, equivalently, the shortest
distance between reciprocal-lattice
planes (McPherson, 2009). The overall
resolution dFSC of a cryo-EM map is
usually defined as the maximum spatial
frequency at which the information
content of the map is reliable (Penczek,
2010). The value is obtained by
analyzing the Fourier shell correlation
(FSC) for two cryo-EM half-maps
binned in resolution shells (van Heel &
Harauz, 1986). If the macromolecule is
structurally heterogeneous (for example
flexible regions in the macromolecule),
a single value for the resolution is
most likely to be inadequate. A ‘local
resolution’ is thus assigned to different
map regions (Cardone et al., 2013;
Kucukelbir et al., 2014).
In Phenix, the resolution of cryo-EMmaps can be estimated
with the newly developed tool Mtriage (phenix.mtriage;
Afonine, Klaholz et al., 2018) using several different approa-
ches, some of which fundamentally differ from dFSC. The tool
also summarizes map statistics. As the map resolution strongly
influences the decisions made in subsequent steps, it is
important to obtain a reliable estimate.
3.3. Common map tools
Several new tools are available to analyze cryo-EM maps
(or any map). In the context of molecular densities, a map is a
3D grid of density values. The map has an origin and a
gridding (the distance between neighboring grid points). A
map typically extends only over grid points where the values
are nonzero (and a buffer), but it is possible that a majority of
map points are zero or very small. Especially for cryo-EM, the
molecules can have symmetry (such as viruses) and the map
will have the same symmetry. The following tools analyze
maps and perform some basic operations.
(i) Show map info (phenix.show_map_info) lists the prop-
erties of a map, such as origin, grid points, unit cell and map
size.
(ii) Map box (phenix.map_box) cuts out a box from a large
map.
(iii) Some molecules, such as viruses, can have high internal
symmetry. It can thus be beneficial to reduce the map to the
repeating unit. Map symmetry (phenix.symmetry_from_map)
finds such symmetries and Map box can extract the unique
part of the map.
(iv) The tool Combine focused maps (phenix.combine_
focused_maps) creates a weighted composite map from a set
of locally focused maps and associated models, where each
part of each map is weighted by its correlation with the
corresponding model.
4. Optimizing maps
4.1. X-ray
To calculate maps, the phase information is required. As
phases are lost in the diffraction experiment, they have to be
recovered by additional experiments or by computational
procedures. In Phenix, phases can be determined by experi-
mental phasing or by molecular replacement (Adams, Afonine
et al., 2009). Once an initial set of phases is known, they can be
improved by optimizing electron-density maps or by opti-
mizing an atomic model from which phases are calculated.
4.1.1. Experimental phasing. Experimental phasing relies
on the properties of a few special atoms in the macromolecule.
The special properties can be a large number of electrons,
anomalous scattering, or a combination of both (reviewed by
Dauter & Dauter, 2017). Phasing is then performed in two
steps: (i) the properties are exploited to determine the loca-
tion of the special atoms (the substructure) and (ii) knowledge
of the substructure in one or more crystals is used to deduce
phase information for the entire macromolecule.
AutoSol (phenix.autosol) is a comprehensive, automatic
tool that performs experimental phasing with the MAD, MIR,
SIR or SAD methods3 (Terwilliger et al., 2009). The program
locates the substructure, estimates phases, performs density
modification, identifies noncrystallographic symmetry (NCS),
and builds and refines a preliminary model. To carry out the
tasks, AutoSol uses the Phenix tools HySS (Hybrid Substruc-
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Figure 6
The primary tools for cryo-EM in Phenix.
3 MAD, multiple-wavelength anomalous diffraction; MIR, multiple isomor-
phous replacement; SIR, single isomorphous replacement.
ture Search; Grosse-Kunstleve & Adams, 2003; Bunko´czi et al.,
2013), SOLVE (Terwilliger & Berendzen, 1999), Phaser
(McCoy et al., 2007), RESOLVE (Terwilliger, 2002), Xtriage
and phenix.refine (Afonine et al., 2012).
4.1.2. Molecular replacement. Molecular replacement
(MR) is used to solve structures when a structurally similar
model (homologue) is available (Hoppe, 1957; Rossmann,
1972; Blow et al., 2012). Success in MR calculations is deter-
mined by how much signal can be extracted from the data
using a particular model. This depends on a combination of
the model quality and completeness, the resolution of the data
and the number of diffraction observations (Oeffner et al.,
2018). For typical cases involving crystals of medium-sized
proteins diffracting to moderate resolution, the sequence
identity between the molecule and the homologue should be
greater than 25–30% and the r.m.s. deviation between C
atoms should be less than 2.0 A˚ (Taylor, 2010). The search
model can be enhanced by trimming off parts of the model
that are unlikely to be preserved in the target structure using
Sculptor (phenix.sculptor; Bunko´czi & Read, 2011). The MR
method consists of determining the orientation and position
that places each copy of the homologue in the unit cell
containing the unknown structure, judged by matching the
calculated structure factors to the observed structure factors.
An initial electron-density map is then calculated with the
phases from the homologue and the observed structure factors
(Evans & McCoy, 2008).
Phaser (phenix.phaser) applies maximum-likelihood prin-
ciples (Bayesian probabilities) to crystal structure solution by
MR, by single-wavelength anomalous diffraction (SAD), or by
a combination of both (MR-SAD) (McCoy et al., 2007). In
common with most MR algorithms, it divides the six-dimen-
sional search problem for each copy into a three-dimensional
rotation search followed by a three-dimensional translation
search. The use of maximum likelihood accounts for the
effects of model imperfections and measurement error in the
diffraction observations. In addition, likelihood provides a
framework for the use of ensemble models created with
Ensembler (phenix.ensembler) and for exploiting the place-
ment of one copy to increase the signal of the search for
another copy (McCoy et al., 2007).
4.1.3. Density modification. As the initial phases are often
quite inaccurate, they need to be improved by exploiting prior
knowledge about electron-density distributions in crystals
(Podjarny et al., 1996). Examples of methods to improve
phases are solvent flattening, histogram matching and, if NCS
is present, noncrystallographic symmetry averaging.
Several Phenix programs carry out density modification.
phenix.density_modification performs iterative phase improve-
ment with RESOLVE (Terwilliger, 2000), including the use
of NCS and electron-density distributions. phenix.multi_
crystal_average improves phases iteratively and averages
electron density, both within a crystal and between crystals.
Phenix.ncs_average can be used to average the electron
density for molecules related by NCS.
4.2. Cryo-EM: map optimization
In the crystallographic case, map improvement is achieved
by the manipulation of phase information, with the diffraction
intensities (or amplitudes) remaining unchanged.4 In contrast,
cryo-EM maps are improved by methods such as sharpening
and blurring that typically modify the amplitudes of Fourier
coefficients, leaving the phases unchanged. Cryo-EMmaps can
appear smooth and lack a high level of detail (contrast)
because high-resolution amplitudes of corresponding Fourier
map coefficients decay from causes such as radiation damage,
sample movement, sample heterogeneity and errors in the
reconstruction procedure. However, sharpening can reveal the
high-resolution details concealed in a cryo-EM map (Rosen-
thal & Henderson, 2003; Ferna´ndez et al., 2008).
The recently developed program Autosharpen map
(phenix.auto_sharpen) performs map sharpening by opti-
mizing the detail and connectivity of a cryo-EM map
(Terwilliger, Sobolev et al., 2018).
5. Obtaining a model that fits the experimental data
To determine the structure of a macromolecule, a model must
be built that fits the experimental data. Cryo-EMmaps contain
phase information, but they often have low resolution (Fig. 7),
which makes interpretation difficult. For both techniques, but
especially in the case of cryo-EM, the molecules can be very
large, so that automated procedures are preferred over
manual interpretation wherever feasible.
5.1. X-ray
Automatic model building is performed after phasing
because the models from MR or AutoSol might be too
incomplete to carry out refinement immediately. MR models
typically originate from a homologue model which has a
different sequence and side-chain conformations; it is thus
necessary to build a model according to the sequence of the
target molecule. AutoSol includes a building step, but in order
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Figure 7
Cryo-EM maps deposited per year for different resolution ranges: better
than 3 A˚, 3–4 A˚, 4–5 A˚ and worse than 5 A˚.
4 Exceptions exist: for example, some procedures fill in missing reflections with
hypothetically derived values (Sheldrick, 2008).
to optimize runtime it creates a preliminary model that can be
further improved.
AutoBuild (phenix.autobuild) is an automated system for
model rebuilding and completion (Terwilliger et al., 2008).
AutoBuild uses RESOLVE, Xtriage and phenix.refine to build
an atomic model, refine it and improve it with iterative density
modification, refinement and model building.
5.2. Cryo-EM
To obtain a model that fits the cryo-EM map, the following
procedures are available.
5.2.1. Docking. A docking procedure is used if the model or
a part of the model is already known (Roseman, 2000) but has
not yet been placed into the map. For example, the cryo-EM
map might show a molecular complex assembled from
components available from other experiments (such as
crystallography). These components are then docked into the
cryo-EM map to obtain a model for the entire complex.
The new tool Dock in map (phenix.dock_in_map) docks
one or several models into a map (Terwilliger, 2018). The
routine uses a convolution-based shape search to find a part of
a map that is similar to the model. The shape search applies
the following key elements. An initial search, focusing on the
overall shape of the molecule, is performed at lower resolu-
tion. This initial search is performed without rotation to
optimize runtime; it can optionally be supplemented by
matching the moments of inertia of the model and map. If the
placement is satisfactory, it is optimized using real-space rigid-
body refinement with the full resolution of the map.
5.2.2. Model building. If the structure of the molecule or of
its components is unknown, the model has to be built ab initio
into the cryo-EM map. This task is challenging because the
molecules are typically very large, chain tracing is difficult at
low resolution and the effective resolution can be even lower
in some regions. Manual interpretation of cryo-EM maps is
therefore time-consuming and error-prone, so automatic
procedures are desirable.
The recent tool Map to model (phenix.map_to_model)
interprets a cryo-EM map and builds an atomic model
(Terwilliger, Adams et al., 2018). All steps are performed
automatically. Firstly, the map is sharpened with Autosharpen
map (Section 4.2). The unique parts of the structure are then
identified by taking the reconstruction symmetry into account.
The procedure also identifies which parts of the map corre-
spond to protein or RNA/DNA. After atomic models have
been generated, they are real-space refined using secondary-
structure restraints (Section 6.1.3). To obtain optimal building
results, the resolution of the map should be 4.5 A˚ or better.
6. Refinement
Models from the building or phasing steps are approximate
and need to be improved; for example, side chains may not fit
the density, and water molecules and ligands are likely to be
missing. Refinement is the process of improving the para-
meters of a model until the best fit is achieved between
experimental and model-calculated data. The parameteriza-
tion of an atomic model mainly depends on the data quality
and the current stage of refinement. Generally, the para-
meterization is chosen such that a simpler model is used at the
beginning (such as rigid body) and a more complex model is
used towards the end. The target function guides the refine-
ment by linking the model parameters to the experimental
data and by scoring model-versus-data fit. For reciprocal-
space refinement, the target function (T) is expressed through
structure factors (or diffraction intensities). For real-space
refinement, the target is formulated in terms of a map. In both
cases, the process alternates automated refinement with
validation and either manual or automated model corrections.
6.1. Restraints
Crystallographic and cryo-EM refinements need additional
information because there are generally too many model
parameters compared with the amount of experimental data
(unless the resolution is better than 1 A˚). Restraints intro-
duce information and modify the target function by creating
relationships between independent parameters. Using the
example of restrained bond lengths, the coordinates of the two
atoms are independent while the restraint keeps their distance
within a certain target value and imposes a penalty if it devi-
ates too much. Other restraints are imposed typically on bond
angles, dihedrals, planes, chirality and coupling of atomic
displacement parameters (ADPs) between bonded or neigh-
boring atoms (Evans, 2007).
If restraints are used, the target function is a sum of an
experimental-data component (Tdata) and a weighted
restraints-based component (wrestraints  Trestraints),
T ¼ Tdata þ wrestraints  Trestraints: ð1Þ
6.1.1. Stereochemical restraints. Proteins and nucleic acids
(RNA and DNA) are composed of amino acids and nucleo-
tides, respectively. The structures of these components are
known from small-molecule crystallography, with the
assumption that they are similar when they assemble to form a
macromolecule. For bond lengths and angles, Phenix makes
use of the CCP4 monomer library restraints (Engh & Huber,
1991; Vagin & Murshudov, 2004; Vagin et al., 2004) in protein
side chains and somewhat modified classic values for nucleic
acids (Clowney et al., 1996; Gelbin et al., 1996). Planarity,
dihedral angles and chirality are also restrained. Recent
additions to the restraints used in Phenix include the confor-
mation-dependent library (Berkholz et al., 2009; Moriarty et
al., 2014, 2016), which restrains the protein main chain as a
function of the backbone dihedral values. Ribose-pucker and
base-type-dependent dihedral restraints are available for
RNA (Jain et al., 2015). Algorithms, as opposed to libraries,
are also used to provide stereochemical restraints. Linking,
including metal and metal cluster coordination (Moriarty &
Adams, 2019), covalent bonding of standard and nonstandard
carbohydrates and other specialized entity specific restraints
can be performed automatically.
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6.1.2. Ligand restraints. Ligands are small molecules that
are bound covalently or noncovalently to a macromolecule.
While ligands can be naturally present, they can be also arti-
facts from reagents used for sample preparation or they can be
introduced to investigate binding properties. Ligands in a
model need to be refined and therefore need restraints. Some
ligands are very common, so that geometry restraints are
available in dictionaries (Vagin et al., 2004; N. W. Moriarty &
P. D. Adams, http://sourceforge.net/projects/geostd) which can
be obtained and updated from a number of sources (Moriarty
& Adams, 2019). Other ligands are rare or novel, requiring
that restraints be generated on a case-by-case basis.
Phenix has several tools for generating and handling ligand
restraints. eLBOW (phenix.elbow) automatically generates
geometry restraints for novel ligands or improves restraints
for standard ligands (Moriarty et al., 2009). ReadySet
(phenix.ready_set) prepares a model for refinement by
generating all necessary ligand restraints with eLBOW and
updating the model file to reflect atom name changes from the
new restraints. The tool REEL includes a 3D view of the
ligand and a tabular view of the restraints, so that target values
and standard deviations can be edited easily (Moriarty et al.,
2017).
6.1.3. Other restraints. Several other types of restraints are
available in Phenix tools.
(i) Secondary-structure restraints. When data resolution is
low, secondary-structure elements (helices and sheets in
proteins, base pairs and stacking pairs in nucleic acids) might
not correctly maintain their conformation; for example, a helix
can lose its regular arrangement. Restraining the hydrogen
bonds in the secondary-structure element can help to maintain
the regular structure (Headd et al., 2012).
(ii) Ramachandran-plot restraints. The backbone dihedral
angles can be restrained to stay in the allowed regions of the
Ramachandran plot (Oldfield, 2001; Emsley et al., 2010; Headd
et al., 2012). These restraints can prevent the model from
degrading at low resolution when the conformation is
approximately correct, but should be used with caution
because they can result in an incorrect local conformation
minimum when the model geometry is poor (Richardson et al.,
2018).
(iii) Parallelity restraints. Molecules may contain planar
atom groups that are approximately parallel to each other,
such as base pairs and stacking pairs in nucleic acids.
Parallelity restraints keep the atom groups parallel (Sobolev et
al., 2015; Richardson, 2015).
(iv) Rotamer-specific restraints. These restraints lock a
particular -angle configuration of an amino-acid residue side
chain to preserve its valid rotameric state.
(v) NCS restraints. If the asymmetric unit contains two
or more similar copies of the same molecule, torsion- or
Cartesian-based NCS restraints can be used. NCS-related
atoms can be identified automatically or be defined by the
user. Torsion-based restraints are generally preferred because
they require little or no manual intervention to account for
common features such as domains that are very similar in
structure but differ in relative orientation (Headd et al., 2014).
(vi) Reference-model restraints. If the data have low reso-
lution, it can be helpful to use a related structure determined
at higher resolution as a reference model to steer refinement
(Headd et al., 2012).
6.2. X-ray: phenix.refine
For crystallographic data, refinement is usually performed
in reciprocal space, i.e. the parameters of the model are
changed so that model-derived structure factors match
experimental structure-factor amplitudes or intensities. The
refinement target in Phenix can be expressed either as a least-
squares or a maximum-likelihood target. Model parameters,
which describe the crystal content and its properties, are a
combination of (i) atomic parameters, such as coordinates,
ADPs, occupancies and scattering factors, and (ii) non-atomic
parameters, which describe contributions arising from bulk
solvent, twinning and crystal anisotropy.
phenix.refine performs crystallographic structure refine-
ment of atomic and non-atomic model parameters against
experimental data (Afonine et al., 2012) at low to ultrahigh
resolutions. Each refinement run begins with bulk-solvent
correction and anisotropic scaling (Afonine et al., 2005, 2013).
The subsequent refinement strategy can be adapted to the
data resolution. Useful strategies at low resolution (or in the
initial stages) are rigid-body refinement (Afonine et al., 2009),
simulated-annealing refinement in Cartesian or torsion-angle
space (Grosse-Kunstleve et al., 2009) and the detection and
use of NCS (Kleywegt & Jones, 1995). ADP parameterizations
include the translation/libration/screw (TLS) model for the
movement of groups treated as rigid (Schomaker & True-
blood, 1968; Urzhumtsev et al., 2016; Afonine, Adams et al.,
2018) as well as individual isotropic, anisotropic and grouped
isotropic ADPs. At ultrahigh resolution (better than 0.7 A˚),
the interatomic scatterer model can account for residual
density from bonding effects (Afonine et al., 2007). The
program also offers occupancy refinement for any user-
defined atoms. Water molecules can be placed and updated
automatically, and improbable side-chain rotamers can be
replaced. In the later stages of refinement it is worthwhile
adding H atoms, since they participate in most intermolecular
and intramolecular contacts and their presence enables the
identification of steric clashes and hydrogen bonds. H atoms
can be added at nuclear positions or at electron-cloud center
positions (Deis et al., 2013).
phenix.refine is designed to be flexible so that multiple
refinement strategies can be combined with each other and
applied to any selected part of the model in a single run. As
there are several hundred parameters, the protocols can be
customized for specific needs. The phenix.refine graphical user
interface (GUI) is integrated with Coot (Emsley et al., 2010)
and PyMOL (DeLano, 2002), so that refined models and
associated maps can be readily displayed and analyzed.
While phenix.refine is the main crystallographic refinement
program of Phenix, the following integrated alternatives exist.
(i) A recent addition integrates the Amber molecular-
mechanics force field (Case et al., 2018) for restraints with the
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functionality of phenix.refine. Amber uses energy-based
geometry terms and adds electrostatics and van der Waals
attractive/dispersive interactions. Amber refinement in Phenix
has been shown to improve model quality, especially sterics
and hydrogen bonding at lower resolutions, and to reduce
overfitting (Moriarty et al., article in preparation).
(ii) Ensemble refinement (phenix.ensemble_refinement)
combines crystallographic refinement with molecular
dynamics to produce ensemble models fitted to diffraction
data (Burnley et al., 2012). The ensemble models can contain
50–500 individual copies and can simultaneously account for
anisotropic and anharmonic distributions.
(iii) DEN refinement (DEN, deformable elastic network)
uses a restraint network to maintain local model geometry
while allowing larger global domain motions over the course
of several cycles of simulated annealing. The protocol is
particularly useful for low-resolution diffraction data
(Brunger et al., 2012).
(iv) Rosetta refinement (phenix.rosetta_refine) integrates the
Rosetta method for conformational sampling (DiMaio et al.,
2013) with the X-ray targets, ADP refinement and map
generation in phenix.refine. This tool is useful at low resolu-
tion, where it combines a wide radius of convergence across
distinct local minima with realistic geometry. It can also be
used to prepare crystal structures for further modeling in
Rosetta.
6.3. Cryo-EM: phenix.real_space_refine
The outcome of the single-particle cryo-EM reconstruction
is a three-dimensional map, so it is natural to perform
refinement of the model in real space. Phases are experi-
mentally determined and are not improved by the procedure.
The recently developed tool phenix.real_space_refine was
specifically designed to perform refinements in real space
(Afonine, Poon et al., 2018). The algorithm uses a simplified
refinement target function that makes calculations faster, so
that optimal data-restraint weights can be identified with little
runtime cost. In addition to standard restraints on covalent
geometry, phenix.real_space_refine makes use of secondary-
structure, Ramachandran-plot and rotamer-spacific restraints
as well as internal molecular-symmetry constraints. The
default mode performs gradient-driven minimization of the
entire model, but optimization can also be performed using
simulated annealing, morphing (Terwilliger et al., 2013), rigid-
body refinement and systematic side-chain improvement
(Oldfield, 2001). As is the case for reciprocal-space refine-
ment, real-space refinement should be alternated with
validation and manual corrections. The real-space refinement
procedure is robust and works at resolutions from 1 to 6 A˚.
6.4. Tools for neutron crystallography
6.4.1. Adding H/D atoms. The crystals used for neutron
diffraction experiments contain H, D or both H and D atoms.
If both isotopes are present, some sites (labile or exchangeable
sites) can be shared by H and D, i.e. some molecules have D at
a particular site, while others have H.
ReadySet (phenix.ready_set) adds H or D atoms to a model
file using the Reduce algorithm (Word, Lovell, Richardson
et al., 1999). In particular, the tool can add H/D atoms at
exchangeable sites of protein amino acids and H or D to
water-molecule O atoms. At labile sites, H atoms are placed in
alternative location ‘A’ and the corresponding D atoms are
placed in location ‘B’.
6.4.2. Joint refinement in phenix.refine. Owing to fairly
prohibitive experimental demands, neutron diffraction data
from macromolecules typically have low data completeness
and a low signal-to-noise ratio. Furthermore, the model
contains H (or D) atoms as independent parameters,
increasing the number of variables significantly. As an X-ray
structure is usually available before a neutron experiment is
conducted, it is possible to refine a single model of a macro-
molecule simultaneously against X-ray and neutron data. This
strategy, called joint X-ray and neutron refinement (joint XN
refinement), ameliorates the data-to-parameters ratio by
increasing the amount of experimental data used in refine-
ment, leading to more complete and accurate models
(Coppens, 1967; Orpen et al., 1978; Wlodawer, 1980;
Wlodawer & Hendrickson, 1982).
Macromolecular models can be refined with phenix.refine
using neutron data or X-ray and neutron data simultaneously
(Adams, Mustyakimov et al., 2009; Afonine et al., 2010). The
program automatically detects exchangeable H/D sites in the
model and ensures that the sum of occupancies is equal to one.
The position of H (or D) atoms can be refined with a ‘riding
model’ (Busing & Levy, 1964; Sheldrick & Schneider, 1997) or
individually. All standard tools available for X-ray refinement
(Section 6.2) are also available for refinement using neutron
data.
7. Validation
Validation indicates good parts and highlights problems in
macromolecular models, and should guide corrections
throughout the structure-solution process. In particular, the
refinement stage benefits from validation: the process consists
of cycles of validation, rebuilding (either manual or auto-
mated) and automated refinement, which are repeated until a
satisfactory model is obtained. As problems are corrected, the
model quality, refinement behavior and even the density map
quality (for X-ray and neutron) all improve.
Validation addresses data, model and model-versus-data
quality. This section covers model and model-versus-data
quality, as data quality has already been described in Section 3.
There are many well established metrics. with new ones being
developed to cover emerging needs. Some metrics are global
(such as Rfree), while others are local (such as a Ramachandran
outliers), but each local measure is usually also collected into a
global score (such as the clashscore; Word, Lovell, LaBean et
al., 1999). The most diagnostic and reliable validation criteria
are those not used in the refinement target, providing inde-
pendent direction for rebuilding.
In Phenix, validation of crystallographic or cryo-EM data
and models is performed with the respective Comprehensive
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validation GUIs or on the command line. The underlying
principles behind model validation are the same for any
experimental method. A good model should make chemical
sense and be consistent with empirical statistics for high-
quality prior structures. The most useful validation criteria
depend on the resolution of the data. Model-versus-data
validation depends on the type of experimental data and
requires that the model explains its own data well. Generally,
the goal is not zero outliers, but as few outliers as feasible
(Richardson, Williams, Hintze et al., 2018). Ideally, each
outlier should be explainable by reference to its environment
(for example hydrogen bonding and/or steric packing stabil-
izing a rotamer outlier) and/or by the experimental data.
7.1. Model validation
In Phenix, model validation is provided in the Compre-
hensive validation GUI. Overall model statistics are presented
in a summary chart with local scores as graphic plots and as
tables that list the outliers on each criterion. Model-validation
tasks are essentially identical to the MolProbity web service
(http://molprobity.biochem.duke.edu/; Chen et al., 2010;
Richardson, Williams, Hintze et al., 2018; Williams, Headd et
al., 2018).
The Comprehensive validation tool uses bond-length and
angle target values for proteins, nucleic acids and ligands from
the same libraries as are applied for refinement restraints
(Section 6.1). Conformational, steric and some special-
purpose metrics use the algorithms developed for MolProbity
(Williams, Headd et al., 2018) and implemented in cctbx
(Section 9). C deviations diagnose side chain–backbone
incompatibility around the C tetrahedron (Lovell et al., 2003)
except when covalent geometry restraints need to be so tight
at low resolution that a C atom cannot deviate from ideal
even if its position is incorrect.
Conformational validation relies on the smoothed, multi-
dimensional distributions for dihedral-angle combinations
from quality-filtered reference data inMolProbity (Chen et al.,
2010; Williams, Headd et al., 2018). Ramachandran backbone
scores use six ’,  distributions that have quite different
outlier contours: general, Ile/Val, Gly, pre-Pro, trans-Pro and
cis-Pro (Read et al., 2011). Fig. 8(a) shows the underlying pre-
Pro data distribution and Fig. 8(b) shows the pre-Pro plot for a
query model as shown in the validation GUI. Side-chain
rotamer distributions have recently been updated (Hintze et
al., 2016). Omega distributions flag cis or twisted peptides.
RNA ribose pucker outliers are diagnosed by a simple rela-
tionship between the well fit 30 phosphate and glycosidic bond
direction (Richardson et al., 2008), which also enables pucker-
specific geometry targets in refinement (Adams et al., 2010).
Steric validation is accomplished by adding and optimizing
H atoms with Reduce and calculating their all-atom contacts
with Probe (Word, Lovell, Richardson et al., 1999; Word,
Lovell, LaBean et al., 1999). An overall measure, called
clashscore, is the number of serious clashes (non-hydrogen-
bond overlap  0.4 A˚) per 1000 atoms. Reduce can also
correct Asn/Gln/His ‘flips’ and suggest His protonation.
Clashes flag problems at any resolution if they occur, but it is
possible that the clashscore can be artificially reduced owing
to tight nonbonded distance restraints. At high resolution,
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Figure 8
Ramachandran ’,  plots for the pre-Pro case. (a) The reference distribution of 60 000 well determined pre-Pro residues, with contours that enclose the
favored 98% of the data (thin green lines) and that exclude the outliers (thick green lines). (b) A pre-Pro Ramachandran plot in the Phenix GUI for a
query structure, showing two labeled outliers in red. Note that pre-Pro is very different from a general case Ramachandran plot.
clashes flag incompatibilities within each alternate conforma-
tion model or in disordered regions where geometry and steric
restraints have been downweighted or removed.
The CaBLAM analysis (Williams, Headd et al., 2018) was
recently developed to validate protein backbone conforma-
tions in models determined at low resolution (2.5–4 A˚), where
it is difficult to determine peptide orientations as carbonyl O
atoms cannot be discerned in density maps (this applies for
crystallography and for cryo-EM). CaBLAM uses virtual C
dihedrals to determine the local chain trace along with a
virtual CO dihedral to diagnose where a peptide orientation is
incompatible with it. CaBLAM outliers are not subject to
overfitting, so they provide a less biased quality indicator.
Most but not all CaBLAM outliers at the 1% level flag a real
problem, which usually requires changing the peptide orien-
tation considerably rather than tweaking it across a contour
boundary. They can often be corrected manually by modifying
peptide orientations or by regularizing the local secondary
structure.
Several rare but serious problems are now flagged if they
occur, such as cis-non-Pro peptides, which are genuine (and
typically have a clear structural role) for only one in 3000
residues and have been grossly overused, especially at low
resolution (Croll, 2015; Williams, Videau et al., 2018). Cis-non-
Pro peptides cannot be justified by experimental data at
resolutions lower than 2.5 A˚ and should be modeled only if
known from other resources (Richardson, Williams, Videau et
al., 2018). H and D atoms are now analyzed if they are present,
summarizing relevant properties and flagging issues with H, D
or exchanged sites, such as missing atoms, unusual geometry
and unlikely occupancies. This is of particular use for models
determined by neutron diffraction (Liebschner et al., 2018).
In the Phenix GUI, the results from all specific validations
are seamlessly integrated with the graphics programs Coot and
PyMOL (Fig. 9). Outliers of any type are listed as a table,
where clicking on an outlier will recenter the graphics window
on that atom or residue. If experimental data were supplied,
maps will be displayed as well. The KiNG Java-based viewer
(Chen et al., 2009) set up by phenix.kinemage displays all
model-validation outliers in 3D to highlight local clusters of
outliers around single serious problems. Generally, the inte-
gration of validation results with graphics programs reduces
the effort that is required to fix problems. An extensive guide
to the interpretation and use of model validation is available
from the Proceedings of the 2017 CCP4
Study Weekend (Richardson, Williams,
Hintze et al., 2018).
7.2. Model versus data validation
7.2.1. Comprehensive validation:
crystallography. The overall agreement
between the model and the diffraction
data is measured by R factors, which
evaluate the difference between the
observed (Fobs) and calculated (Fmodel)
structure-factor amplitudes,
R ¼PjFobsj  jFmodelj

=
P jFobsj:
ð2Þ
The Rwork value is calculated on the
large subset of the diffraction data used
for refinement. For cross-validation,
Rfree is calculated on a subset of the data
(typically about 2000 reflections) that
are not used in refinement (Bru¨nger,
1992). If Rfree increases while Rwork
decreases, the model might be
incorrectly parameterized or the
refinement strategy needs to be revised
(Kleywegt & Bru¨nger, 1996).
phenix.refine reports Rwork and Rfree
values after refinement; R-factor plots
show how the values change during the
refinement run. The distribution of R
factors across resolution shells can be
used to pinpoint anomalies such as ice
rings, saturated reflections or problems
with bulk-solvent modeling.
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Figure 9
Screenshots of the cryo-EM Comprehensive validation tool and a Coot window. Clicking on the item
in the table of cis/twisted peptides (highlighted in gray) recenters the Coot window on that peptide.
While R factors are calculated in reciprocal space, real-
space correlation coefficients measure how the model fits the
density map locally, for example at the chain, residue or atom
level. In Phenix validation, residues with low real-space
correlation coefficients are listed in a table linked to graphics
programs, allowing recentering on the residue in question to
enable analysis and correction. This is useful because the
correlation may be sometimes misleading.
The Polygon tool combines six diverse measures (average
ADP, r.m.s.d. bonds and angles, clashscore, Rwork and Rfree) to
visualize the refinement outcome in radial, one-dimensional
histograms (Urzhumtseva et al., 2009). Lines connecting the
scores form a hexagonal polygon that should be small
and approximately symmetric. This is similar to the
wwPDB slider graphic (https://www.wwpdb.org/validation/2017/
XrayValidationReportHelp#overall_quality) that conveys
model quality at a glance.
7.2.2. Comprehensive validation: cryo-EM. While valida-
tion methods in crystallography have had decades to mature,
cryo-EM has only recently evolved into a routine technique
for near-atomic resolution models (Ku¨hlbrandt, 2014). The
search for appropriate metrics to assess model and model-to-
data fit is therefore still ongoing (Afonine, Klaholz et al.,
2018). One measure of agreement between a model and a map
is the model–map correlation coefficient (map CC; Bra¨nde´n &
Jones, 1990; Jones et al., 1991). In reciprocal space, model-
versus-data agreement is assessed by curves of the Fourier
shell correlation (FSC) as a function of resolution. The map–
model FSC is the correlation between the Fourier coefficients
computed by Fourier transformation of the 3D reconstruction
and of a model-based map (Rosenthal & Henderson, 2003).
The Phenix Comprehensive validation tool (Fig. 9) for cryo-
EM reports newly developed model and map-to-model quality
indicators (Afonine, Klaholz et al., 2018), such as CaBLAM
outliers, the CC using the entire map (CCbox), the CC within a
mask (CCmask) and the map–model FSC curve. Plots of
average CC values per chain and per residue help to identify
problematic regions of the macromolecule.
The EMRinger (phenix.emringer) score quantifies how well
the model backbone places side chains in density peaks that
are consistent with rotameric conformations (Barad et al.,
2015).
8. Other tools
8.1. X-ray
8.1.1. Electron-density maps. Electron-density maps are
routinely used to guide manual model building of crystallo-
graphic structures. Below is a selection of tools for map
calculations in Phenix. The Phenix documentation includes a
more complete list (http://www.phenix-online.org/docu-
mentation/).
(i) Polder maps (phenix.polder) uncover weak difference
densities by locally excluding bulk solvent (Liebschner et al.,
2017). They are useful for ligands and residues protruding into
the solvent area.
(ii) Composite OMIT maps (phenix.composite_omit_maps)
are generated by combining OMIT maps of specific regions to
obtain a map covering the entire contents of the unit cell
(Bru¨nger et al., 1998). This map is relatively bias-free without
severely compromising phase quality.
(iii) Feature-enhanced maps (FEM; phenix.feature_
enhanced_map) modify a 2mFobs  DFmodel A-weighted map
so that weak signals are strengthened while model bias and
noise are reduced (Afonine et al., 2015).
New metrics to compare crystallographic contour maps
are available in the Map Sigma Level Comparison tool
(phenix.map_comparison; Urzhumtsev et al., 2014).
8.1.2. Structure comparison. It is common to study near-
identical protein structures, such as mutants, proteins with
different ligands or NCS-related copies. Often, it is useful to
compare the structures to find differences and similarities.
The Structure comparison tool (Moriarty et al., 2018)
validates and analyzes similar protein models (>80% sequence
identity). The GUI displays validation outliers and confor-
mational differences between chains in a table, linked to
graphics windows (Coot and PyMOL). Analyses include
ligands, persistent ions and water molecules, rotamers,
Ramachandran angles, missing atoms, secondary structure,
water locations, ! angles and ADPs. The extracted chains and
electron-density maps can be superimposed onto a common
frame of reference. The chains may subsequently be edited
in Coot to ensure consistency and/or fix errors, and then
recovered in their original orientations for further refinement
and rebuilding.
8.1.3. Ligand fitting. The goal of a crystallographic study is
often to understand the interaction of a small-molecule ligand
with a macromolecule. It is also common to discover density
for an unanticipated small molecule. In both cases, it is
necessary to fit the ligand into the electron density to complete
the atomic model.
Phenix has several tools to investigate ligands.
(i) LigandFit (phenix.ligand_fit) identifies difference density
peaks in a map and tries to place a user-defined ligand in the
density (Terwilliger et al., 2006, 2007).
(ii) Guided ligand replacement (phenix.guided_ligand_
replacement) uses prior knowledge about ligand binding in a
protein to assist the fitting of a similar ligand into the same or
a similar protein (Klei et al., 2014). This tool helps study a
series of compounds for the same or related macromolecular
targets.
(iii) Ligand identification (phenix.ligand_identification)
analyzes difference density peaks to reveal which ligand is
likely to be present (Terwilliger et al., 2006, 2007). The tool
uses a library of 180 most frequently observed ligands in the
PDB and ranks each molecule by density fit and chemical
interactions with the macromolecule.
8.2. Using other programs within Phenix
Several programs from external developers can be executed
in Phenix. Most require separate installation.
feature articles
872 Liebschner et al.  Recent developments in Phenix Acta Cryst. (2019). D75, 861–877
(i) MR-Rosetta (phenix.mr_rosetta) uses homology
modeling in the Rosetta program to improve a model before
and/or after MR (DiMaio et al., 2011; Terwilliger et al., 2012).
Once a potential solution is obtained, Rosetta fills in missing
sections and rebuilds the model to improve the fit to the
electron-density map and the phases for map interpretation or
automated model building. This approach is helpful in cases
where the MR model differs greatly from the target.
(ii) ERRASER (Chou et al., 2013) improves RNA backbone
conformations by combining MolProbity clash analysis,
Phenix refinement and a pruned enumeration and optimiza-
tion in Rosetta.
(iii) Conventional restraints may not capture the
influences of intermolecular covalent and nonbonded inter-
actions, metal coordination or solvation. The semiempirical
quantum mechanics engine DivCon has been integrated into
phenix.refine to create gradients for a region of interest
(Borbulevych et al., 2014).
(iv) CryoFit uses molecular dynamics to perform flexible
fitting of a model to a cryo-EM map (Kirmizialtin et al., 2015;
Kim et al., 2019). The approach produces a new conforma-
tional model with optimized atomic coordinates and preserved
stereochemistry and secondary structure.
(v) Quantum refinement (Q|R) is a method to refine
macromolecular models with restraints derived from quantum
chemistry instead of library-based restraints (Zheng, Moriarty
et al., 2017; Zheng, Reimers et al., 2017). The Q|R source code
(https://github.com/qrefine/qr-core) uses cctbx (Section 9.1) to
construct a refinement protocol resembling phenix.refine.
(vi) ISOLDE (Croll, 2018) is a plugin to UCSF ChimeraX
(Goddard et al., 2018) for improving low-resolution cryo-EM
or crystal structures. It performs interactively guided simula-
tion with molecular-dynamics flexible fitting against a map and
real-time validation; it will soon be possible to launch it from
the Phenix GUI.
(vii) Cryo-EMmodel building with Pathwalker (Baker et al.,
2012; Chen et al., 2016) will soon be available within Phenix.
Pathwalker can construct protein backbone models directly
from near-atomic resolution cryo-EM density maps using a
modified approach to traveling salesman problem solvers.
When coupled with Phenix tools, such as phenix.pulchra
(Rotkiewicz & Skolnick, 2008) and real-space refinement,
complete atomistic models can be generated within a few
minutes for individual proteins or complexes.
8.3. Tools for model deposition
Several tools are available to facilitate the deposition
process of macromolecular structures.
(i) Generate Table 1 for journal (phenix.table_one) is a tool
for generating the standard table of crystallographic statistics
required by most scientific journals for structure solutions. It
summarizes the validation statistics and calculates merging
statistics for crystallographic data. For cryo-EM structures, the
Comprehensive validation (CryoEM) GUI has a button to
generate a similar table containing the model-validation
statistics as well as map resolution estimates.
(ii) Prepare model for PDB deposition (mmtbx.prepare_
pdb_deposition) adds the sequence information to the model
file. In particular, the tool creates model files in PDBx/mmCIF
format, which have been mandatory for crystallographic
depositions to the PDB since 1 July 2019 (Adams et al., 2019).
(iii) Get PDB validation report (phenix.get_pdb_validation_
report) retrieves the validation report from the wwPDB
through their web interface. By providing the model and
optional data in mmCIF format, the validation report can help
users to identify problems before starting the deposition
process.
9. Infrastructure
9.1. Architecture
Phenix is built on the Computational Crystallography
Toolbox (cctbx), which is an open-source library (https://
github.com/cctbx/cctbx_project) of reusable software compo-
nents for macromolecular structure determination (Grosse-
Kunstleve et al., 2002). The cctbx components are written both
in a compiled language (C++) and a flexible scripting language
(Python; Lutz & Ascher, 1999). This approach is very efficient
because high-level algorithms (such as refinement protocols)
can be rapidly developed in the scripting language, while
computationally intensive algorithms can be implemented in
the compiled language. The Boost.Python Library (http://
www.boost.org/) is used to expose the C++ interfaces, classes
and functions to Python (Abrahams & Grosse-Kunstleve,
2003).
The GUI is scripted through Python and produces a ‘native’
look5 on each operating system. The current Phenix release
(v.1.16) includes GUIs for all major programs. Embedded
graphs are computed with the free matplotlib Python library
(Hunter, 2007). A simple 3D graphics viewer can be used to
display the molecule or to pick atom selections interactively.
9.2. Documentation
The Phenix GUI provides more than 175 tools, with even
more programs available on the command line (500). The
extensive online manual covers about 180 separate HTML
pages, describes GUI and command-line versions of individual
programs and includes tutorials and FAQs. The Phenix
Tutorials YouTube channel (https://www.youtube.com/c/
phenixtutorials; Fig. 10) currently provides 29 tutorial videos.
Each video introduces a Phenix tool, summarizes the input
files and parameters, explains how to run the program and
discusses the results.
10. Conclusion
The Phenix software for macromolecular structure determi-
nation handles data from three experimental methods: cryo-
EM, X-ray diffraction and neutron diffraction. All steps in the
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5 The application takes on the convention, gestures and esthetics of their
operating system.
structure-solution process are addressed by programs that are
tailored for the type of experimental data, but share algo-
rithms where appropriate. Procedures are automated to
minimize repetitive and time-consuming manual tasks as far as
feasible. For the future, the improvement of automated model
building, refinement and validation at low resolution (worse
than 3 A˚) remains a priority; another area of development to
help the structural biology community is the automated
identification, fitting and refinement of ligands, ions and water.
Many challenging opportunities still exist in crystallography
and cryo-EM owing to advances in light sources and instru-
mentation that make it possible to go beyond structure
determination by single-crystal diffraction and single-particle
cryo-EM. For example, free-electron lasers (FELs) and serial
synchrotron crystallography (Chapman et al., 2011; Rossmann,
2014; Diederichs & Wang, 2017; Standfuss & Spence, 2017;
Schlichting, 2015) have opened up new approaches to studying
the dynamics of macromolecules. Therefore, methods are
needed to extract models of molecular motion from time-
resolved diffraction experiments. Diffuse X-ray scattering
(Wall et al., 2014, 2018) can also reveal molecular motions and
lattice disorder, but methods to exploit the information
contained in diffuse scattering are still scarce. Micro-electron
diffraction (MicroED; Liu et al., 2017; Gruene et al., 2018;
Jones et al., 2018; Nannenga & Gonen, 2018) is an emerging
technique to determine high-resolution structures of macro-
molecules. Current procedures for diffraction data will require
fine-tuning to treat MicroED data adequately. Similarly, while
cryo-EM is typically currently applied to large molecules and
complexes, it is becoming increasingly possible to look at
smaller molecules because of improvements in instrumenta-
tion and data processing. Furthermore, the use of focused
refinement of cryo-EM data (von Loeffelholz et al., 2017;
Natchiar et al., 2017) can generate much improved local
reconstructions, but it remains to be seen how these can be
best combined for model generation and subsequent model
refinement. Finally, cryo-tomography, which is a type of elec-
tron microscopy that can probe entire cells and thus enable
the visualization of molecules in situ, nowadays produces
reconstructions at better than 10 A˚ resolution and in some
cases significantly better. There will be an increasing need to
accurately and effectively combine such lower resolution
information with results from high-resolution crystallographic
or cryo-EM experiments.
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